GlassScriptPhysician profile
Mark V Schaverien
NPI 1578933271
$6,817.21
in general payments reported to CMS, 2019-2025
15 companies · $1,716 in 2025
The $1,716 reported for 2025 was more than what 82% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $537 · 2021: $140 · 2022: $885 · 2023: $768 · 2024: $2,771 · 2025: $1,716.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,855 · Long Term Medical Supply Or Device Loan: $1,303 · Travel and Lodging: $97.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,854.79 |
| Long Term Medical Supply Or Device Loan | $1,303.20 |
| Travel and Lodging | $97.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $1,855.23 | 2022-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander, Mentor Siltex Round Spectrum |
| Integra Lifesciences Corporation | $1,513.64 | 2022-2024 | Durasorb Monofilament Mesh |
| Musculoskeletal Transplant Foundation INC. | $895.29 | 2023-2025 | |
| Abbvie INC. | $688.62 | 2023-2024 | Natrelle Saline-Filled Breast Implants |
| Allergan, INC. | $491.10 | 2019-2022 | |
| Baxter Healthcare | $294.75 | 2019-2022 | |
| Kerecis Limited | $226.92 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Organogenesis INC. | $139.65 | 2025 | Puraply Wound Matrix |
| Sientra, INC. | $133.66 | 2022 | |
| Davol INC. | $132.95 | 2022 | |
| Motiva USA, LLC | $130.39 | 2025 | |
| Ethicon US, LLC | $124.98 | 2019 | |
| Sanara Medtech INC. | $101.90 | 2022 | |
| Tei Biosciences INC | $75.02 | 2019 | |
| Tactile Systems Technology INC | $13.11 | 2023 | Entre Plus, Flexitouch Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Schaverien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.